v3.25.2
Summary of Significant Accounting Policies - Schedule of Contract Assets and Deferred Revenues (Details) - DiamiR Biosciences Corp. [Member] - USD ($)
$ in Millions
12 Months Ended
May 31, 2025
May 31, 2024
Schedule of Contract Assets and Deferred Revenues [Line Items]    
Contract costs at beginning
Contract liability at beginning
Contract assets Net change due to billings
Contract liability Net change due to billings
Contract assets Revenue recognized
Contract liability Revenue recognized
Contract costs at ending
Contract liability at ending
Deferred Revenue [Member]    
Schedule of Contract Assets and Deferred Revenues [Line Items]    
Contract liability at beginning
Contract liability Net change due to billings 43,982
Contract liability Revenue recognized
Contract liability at ending 43,982
Unbilled Revenues [Member]    
Schedule of Contract Assets and Deferred Revenues [Line Items]    
Contract costs at beginning
Contract assets Net change due to billings
Contract assets Revenue recognized
Contract costs at ending